BACKGROUND Bicuspid aortic valves are associated with valve dysfunction, ascending aortic aneurysm and dissection.
valves is estimated to be 8 times higher than that in the general population (2), but single-center studies focusing on the long-term risk for dissection after isolated AVR in patients with bicuspid aortic valves have yielded conflicting outcome data (4) (5) (6) (7) (8) , so the indications for concomitant intervention on the thoracic aorta at the time of AVR are controversial (9) . Histopathologic similarities between specimens of aneurysms from patients with bicuspid aortic valves and Marfan syndrome (10, 11) have led to the extrapolation of treatment algorithms for management of the ascending aorta in bicuspid aortic valve disease from aggressive guidelines established for the management of Marfan syndrome (12, 13) , despite the lack of supporting comparative clinical outcome data (14, 15) . This study was designed to test the hypothesis that the natural history of thoracic aortopathy after AVR in patients with bicuspid aortic valve disease is substantially different from that seen in patients with Marfan syndrome. Patients with Marfan syndrome were identified using ICD-9-CM code 759.82, from any hospital admission before or after surgery.
Exclusion criteria were age < 18 years; out-of-state residence; any history of thoracic aortic aneurysm (TAA), thoracic aortic dissection, or thoracic aortic rupture; concomitant thoracic aortic surgery; prior thoracic aortic surgery; prior coronary artery bypass grafting; and prior replacement or repair of any valve (Online Table 1 ). Patients with the following genetic syndromes and inflammatory diseases associated with TAA and dissection also were excluded: Turner syndrome, Ehlers-Danlos syndrome, Shone complex, Takayasu arteritis, giant cell arteritis, Behçet disease, and ankylosing spondylitis (Online Table 1 ). Patients undergoing concomitant coronary artery bypass grafting and other valve surgery were not excluded.
Baseline comorbidities were identified using diagnosis codes from the index hospitalization and all hospitalizations up to 2 years before the index hospitalization (Online Table 2 Values are mean AE SD or n (%). *One condition imposed by the Statewide Planning and Research Cooperative System for access to its data is the undertaking not to publish patient data when the number of patients affected was 10 or less, in order to preserve patient confidentiality. Bicuspid Aortic Valve Versus Marfan Syndrome J U N E 9 , 2 0 1 5 : 2 3 6 3 -9
The indication for surgery was thoracic aortic dissection in 30.8% of cases (n ¼ 20; 37.9% in the control group, 13.6% in the bicuspid valve group, and 50% in the Marfan syndrome group). The 30-day mortality rate after thoracic aortic surgery was 10.8%; the 30-day mortality rate after thoracic aortic surgery for thoracic aortic dissection was 30.0%.
DISCUSSION
In this analysis of a statewide database capturing all admissions to hospitals in New York State, we ob- 
